Donate For Public and Patients Store Search

F010 - Chronic Urticaria and Angioedema: What's New In Pathogenesis and Treatment

Friday, March 1; 9:00 AM - 11:00 AM

Learning Objectives

Following this course, the attendee should be able to:

  • Summarize the pathophysiology of urticaria and angioedema
  • Differentiate urticaria and angioedema subtypes
  • Formulate treatment plans for urticaria and angioedema


This session will provide an overview of the pathophysiology and treatment algorithms of urticaria and angioedema. The majority of the forum will focus on patient presentations highlighting important aspects of urticaria and angioedema clinical presentations and treatments.


  • Baker, Diane Romayne, MD: Aimmune Therapeutics, Inc. – I(Grants/Research Funding); Novartis Pharmaceuticals Corp. – I(Grants/Research Funding); Regeneron – I(Grants/Research Funding); sanofi-aventis – O(Grants/Research Funding);
  • Leslie, Tabi Anika, MBBS: no financial relationships exist with commercial interests.
  • Tharp, Michael D., MD: BestDoctors – C(Fees); Medical Information Network – F(S); Novartis Pharmaceuticals Corp. – C(H); Unilever Home & Personal Care USA – A(Grants/Research Funding);
Friday, March 1
9:00 AM
Dr. Tharp / Urticaria and Angioedema Overview
9:20 AM
Dr. Baker / Angioedema cases
9:50 AM
Dr. Baker / Q&A
9:55 AM
Dr. Baker / Urticaria cases
10:25 AM
Dr. Baker / Q&A
10:30 AM
Dr. Leslie / Urticaria cases
Event Details
  • Date
    Friday, March 1
  • Time
    9:00 AM - 11:00 AM
  • Location
    Room 144A
  • CME Credits
  • Type
  • Michael D. Tharp, MD, FAAD
  • Diane Romayne Baker, MD, FAAD
  • Tabi Anika Leslie, MBBS